nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Vismodegib—Sorafenib—kidney cancer	0.437	1	CrCrCtD
Etoricoxib—PTGS2—kidney cancer	0.129	1	CbGaD
Etoricoxib—CYP2D6—Temsirolimus—kidney cancer	0.023	0.11	CbGbCtD
Etoricoxib—CYP3A4—Everolimus—kidney cancer	0.0217	0.104	CbGbCtD
Etoricoxib—CYP1A2—Pazopanib—kidney cancer	0.0147	0.0702	CbGbCtD
Etoricoxib—CYP3A4—Temsirolimus—kidney cancer	0.0146	0.07	CbGbCtD
Etoricoxib—CYP2C9—Capecitabine—kidney cancer	0.0138	0.066	CbGbCtD
Etoricoxib—CYP2D6—Pazopanib—kidney cancer	0.0121	0.0579	CbGbCtD
Etoricoxib—CYP1A2—Erlotinib—kidney cancer	0.0105	0.0501	CbGbCtD
Etoricoxib—CYP2C19—Sorafenib—kidney cancer	0.00923	0.0442	CbGbCtD
Etoricoxib—CYP2C9—Paclitaxel—kidney cancer	0.00864	0.0413	CbGbCtD
Etoricoxib—CYP2D6—Erlotinib—kidney cancer	0.00863	0.0413	CbGbCtD
Etoricoxib—CYP1A2—Sorafenib—kidney cancer	0.00852	0.0407	CbGbCtD
Etoricoxib—CYP3A4—Pazopanib—kidney cancer	0.00769	0.0368	CbGbCtD
Etoricoxib—CYP2C9—Sorafenib—kidney cancer	0.00768	0.0367	CbGbCtD
Etoricoxib—CYP2D6—Sorafenib—kidney cancer	0.00702	0.0336	CbGbCtD
Etoricoxib—CYP2D6—Vinblastine—kidney cancer	0.00693	0.0332	CbGbCtD
Etoricoxib—CYP3A4—Erlotinib—kidney cancer	0.00549	0.0263	CbGbCtD
Etoricoxib—CYP3A4—Paclitaxel—kidney cancer	0.00502	0.024	CbGbCtD
Etoricoxib—CYP3A4—Sorafenib—kidney cancer	0.00446	0.0213	CbGbCtD
Etoricoxib—CYP3A4—Vinblastine—kidney cancer	0.00441	0.0211	CbGbCtD
Etoricoxib—CYP3A4—Vincristine—kidney cancer	0.00433	0.0207	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—kidney cancer	0.00426	0.0204	CbGbCtD
Etoricoxib—CYP3A4—Sunitinib—kidney cancer	0.00362	0.0173	CbGbCtD
Etoricoxib—CYP3A4—Doxorubicin—kidney cancer	0.00271	0.013	CbGbCtD
Etoricoxib—CYP2C19—urine—kidney cancer	0.00184	0.121	CbGeAlD
Etoricoxib—Vemurafenib—RAF1—kidney cancer	0.00174	0.409	CrCbGaD
Etoricoxib—PTGS2—nephron—kidney cancer	0.00155	0.102	CbGeAlD
Etoricoxib—CYP1A2—urine—kidney cancer	0.0015	0.0986	CbGeAlD
Etoricoxib—CYP2C9—urine—kidney cancer	0.00143	0.0936	CbGeAlD
Etoricoxib—CYP2E1—urine—kidney cancer	0.00135	0.0887	CbGeAlD
Etoricoxib—Vemurafenib—BRAF—kidney cancer	0.0012	0.284	CrCbGaD
Etoricoxib—CYP3A4—urine—kidney cancer	0.00109	0.0714	CbGeAlD
Etoricoxib—CYP2D6—urine—kidney cancer	0.00107	0.0702	CbGeAlD
Etoricoxib—MAPK14—renal system—kidney cancer	0.00106	0.0695	CbGeAlD
Etoricoxib—MAPK14—kidney—kidney cancer	0.00102	0.0672	CbGeAlD
Etoricoxib—Celecoxib—CA9—kidney cancer	0.000545	0.129	CrCbGaD
Etoricoxib—Celecoxib—CA2—kidney cancer	0.00049	0.116	CrCbGaD
Etoricoxib—CYP1A2—renal system—kidney cancer	0.000367	0.0241	CbGeAlD
Etoricoxib—CYP2E1—nephron tubule—kidney cancer	0.000364	0.0239	CbGeAlD
Etoricoxib—CYP2E1—renal system—kidney cancer	0.000331	0.0217	CbGeAlD
Etoricoxib—CYP2E1—kidney—kidney cancer	0.00032	0.021	CbGeAlD
Etoricoxib—CYP2E1—cortex of kidney—kidney cancer	0.000311	0.0204	CbGeAlD
Etoricoxib—PTGS2—renal system—kidney cancer	0.000304	0.02	CbGeAlD
Etoricoxib—PTGS2—kidney—kidney cancer	0.000294	0.0193	CbGeAlD
Etoricoxib—CYP3A4—renal system—kidney cancer	0.000266	0.0175	CbGeAlD
Etoricoxib—CYP2D6—renal system—kidney cancer	0.000262	0.0172	CbGeAlD
Etoricoxib—CYP3A4—kidney—kidney cancer	0.000257	0.0169	CbGeAlD
Etoricoxib—CYP2D6—kidney—kidney cancer	0.000253	0.0166	CbGeAlD
Etoricoxib—Celecoxib—PTGS2—kidney cancer	0.000154	0.0363	CrCbGaD
Etoricoxib—Vismodegib—ABCB1—kidney cancer	0.000112	0.0264	CrCbGaD
Etoricoxib—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	4.51e-05	0.000331	CcSEcCtD
Etoricoxib—Pain in extremity—Doxorubicin—kidney cancer	4.51e-05	0.000331	CcSEcCtD
Etoricoxib—Flushing—Capecitabine—kidney cancer	4.49e-05	0.00033	CcSEcCtD
Etoricoxib—Cardiac disorder—Capecitabine—kidney cancer	4.49e-05	0.00033	CcSEcCtD
Etoricoxib—Cough—Paclitaxel—kidney cancer	4.48e-05	0.000329	CcSEcCtD
Etoricoxib—Asthenia—Sunitinib—kidney cancer	4.48e-05	0.000329	CcSEcCtD
Etoricoxib—Dyspnoea—Gemcitabine—kidney cancer	4.46e-05	0.000328	CcSEcCtD
Etoricoxib—Nausea—Vinblastine—kidney cancer	4.45e-05	0.000327	CcSEcCtD
Etoricoxib—Somnolence—Gemcitabine—kidney cancer	4.45e-05	0.000327	CcSEcCtD
Etoricoxib—Nausea—Everolimus—kidney cancer	4.44e-05	0.000326	CcSEcCtD
Etoricoxib—Diarrhoea—Sorafenib—kidney cancer	4.44e-05	0.000326	CcSEcCtD
Etoricoxib—Hypertension—Paclitaxel—kidney cancer	4.43e-05	0.000326	CcSEcCtD
Etoricoxib—Pruritus—Sunitinib—kidney cancer	4.41e-05	0.000324	CcSEcCtD
Etoricoxib—Angiopathy—Capecitabine—kidney cancer	4.39e-05	0.000323	CcSEcCtD
Etoricoxib—Immune system disorder—Capecitabine—kidney cancer	4.37e-05	0.000321	CcSEcCtD
Etoricoxib—Chest pain—Paclitaxel—kidney cancer	4.37e-05	0.000321	CcSEcCtD
Etoricoxib—Arthralgia—Paclitaxel—kidney cancer	4.37e-05	0.000321	CcSEcCtD
Etoricoxib—Mediastinal disorder—Capecitabine—kidney cancer	4.36e-05	0.000321	CcSEcCtD
Etoricoxib—Anxiety—Paclitaxel—kidney cancer	4.36e-05	0.00032	CcSEcCtD
Etoricoxib—Decreased appetite—Gemcitabine—kidney cancer	4.35e-05	0.00032	CcSEcCtD
Etoricoxib—Hypersensitivity—Dactinomycin—kidney cancer	4.35e-05	0.00032	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	4.34e-05	0.000319	CcSEcCtD
Etoricoxib—Arrhythmia—Capecitabine—kidney cancer	4.32e-05	0.000318	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Gemcitabine—kidney cancer	4.32e-05	0.000318	CcSEcCtD
Etoricoxib—Fatigue—Gemcitabine—kidney cancer	4.32e-05	0.000317	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Vincristine—kidney cancer	4.31e-05	0.000317	CcSEcCtD
Etoricoxib—Cardiac arrest—Doxorubicin—kidney cancer	4.29e-05	0.000315	CcSEcCtD
Etoricoxib—Dizziness—Sorafenib—kidney cancer	4.29e-05	0.000315	CcSEcCtD
Etoricoxib—Pain—Gemcitabine—kidney cancer	4.28e-05	0.000315	CcSEcCtD
Etoricoxib—Constipation—Gemcitabine—kidney cancer	4.28e-05	0.000315	CcSEcCtD
Etoricoxib—Nausea—Erlotinib—kidney cancer	4.28e-05	0.000315	CcSEcCtD
Etoricoxib—Alopecia—Capecitabine—kidney cancer	4.28e-05	0.000314	CcSEcCtD
Etoricoxib—Dry mouth—Paclitaxel—kidney cancer	4.28e-05	0.000314	CcSEcCtD
Etoricoxib—Diarrhoea—Sunitinib—kidney cancer	4.27e-05	0.000314	CcSEcCtD
Etoricoxib—Mental disorder—Capecitabine—kidney cancer	4.24e-05	0.000312	CcSEcCtD
Etoricoxib—Asthenia—Dactinomycin—kidney cancer	4.24e-05	0.000311	CcSEcCtD
Etoricoxib—Confusional state—Paclitaxel—kidney cancer	4.23e-05	0.000311	CcSEcCtD
Etoricoxib—Blood creatinine increased—Doxorubicin—kidney cancer	4.23e-05	0.000311	CcSEcCtD
Etoricoxib—Erythema—Capecitabine—kidney cancer	4.21e-05	0.00031	CcSEcCtD
Etoricoxib—Malnutrition—Capecitabine—kidney cancer	4.21e-05	0.00031	CcSEcCtD
Etoricoxib—Anaphylactic shock—Paclitaxel—kidney cancer	4.19e-05	0.000308	CcSEcCtD
Etoricoxib—Oedema—Paclitaxel—kidney cancer	4.19e-05	0.000308	CcSEcCtD
Etoricoxib—Abdominal pain—Vincristine—kidney cancer	4.17e-05	0.000307	CcSEcCtD
Etoricoxib—Infection—Paclitaxel—kidney cancer	4.16e-05	0.000306	CcSEcCtD
Etoricoxib—Flatulence—Capecitabine—kidney cancer	4.15e-05	0.000305	CcSEcCtD
Etoricoxib—Dysgeusia—Capecitabine—kidney cancer	4.13e-05	0.000303	CcSEcCtD
Etoricoxib—Dizziness—Sunitinib—kidney cancer	4.13e-05	0.000303	CcSEcCtD
Etoricoxib—Feeling abnormal—Gemcitabine—kidney cancer	4.13e-05	0.000303	CcSEcCtD
Etoricoxib—Shock—Paclitaxel—kidney cancer	4.12e-05	0.000303	CcSEcCtD
Etoricoxib—Vomiting—Sorafenib—kidney cancer	4.12e-05	0.000303	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Doxorubicin—kidney cancer	4.12e-05	0.000303	CcSEcCtD
Etoricoxib—Nervous system disorder—Paclitaxel—kidney cancer	4.11e-05	0.000302	CcSEcCtD
Etoricoxib—Thrombocytopenia—Paclitaxel—kidney cancer	4.1e-05	0.000302	CcSEcCtD
Etoricoxib—Rash—Sorafenib—kidney cancer	4.09e-05	0.0003	CcSEcCtD
Etoricoxib—Dermatitis—Sorafenib—kidney cancer	4.08e-05	0.0003	CcSEcCtD
Etoricoxib—Breast disorder—Doxorubicin—kidney cancer	4.08e-05	0.0003	CcSEcCtD
Etoricoxib—Skin disorder—Paclitaxel—kidney cancer	4.07e-05	0.000299	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.06e-05	0.000298	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.06e-05	0.000298	CcSEcCtD
Etoricoxib—Headache—Sorafenib—kidney cancer	4.06e-05	0.000298	CcSEcCtD
Etoricoxib—Muscle spasms—Capecitabine—kidney cancer	4.05e-05	0.000298	CcSEcCtD
Etoricoxib—Diarrhoea—Dactinomycin—kidney cancer	4.04e-05	0.000297	CcSEcCtD
Etoricoxib—Anorexia—Paclitaxel—kidney cancer	3.99e-05	0.000294	CcSEcCtD
Etoricoxib—Gastritis—Doxorubicin—kidney cancer	3.99e-05	0.000293	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Doxorubicin—kidney cancer	3.98e-05	0.000292	CcSEcCtD
Etoricoxib—Muscular weakness—Doxorubicin—kidney cancer	3.98e-05	0.000292	CcSEcCtD
Etoricoxib—Vision blurred—Capecitabine—kidney cancer	3.97e-05	0.000292	CcSEcCtD
Etoricoxib—Vomiting—Sunitinib—kidney cancer	3.97e-05	0.000291	CcSEcCtD
Etoricoxib—Tremor—Capecitabine—kidney cancer	3.95e-05	0.00029	CcSEcCtD
Etoricoxib—Rash—Sunitinib—kidney cancer	3.93e-05	0.000289	CcSEcCtD
Etoricoxib—Dermatitis—Sunitinib—kidney cancer	3.93e-05	0.000289	CcSEcCtD
Etoricoxib—Abdominal distension—Doxorubicin—kidney cancer	3.92e-05	0.000288	CcSEcCtD
Etoricoxib—Headache—Sunitinib—kidney cancer	3.91e-05	0.000287	CcSEcCtD
Etoricoxib—Anaemia—Capecitabine—kidney cancer	3.9e-05	0.000286	CcSEcCtD
Etoricoxib—Hypersensitivity—Vincristine—kidney cancer	3.89e-05	0.000286	CcSEcCtD
Etoricoxib—Nausea—Sorafenib—kidney cancer	3.85e-05	0.000283	CcSEcCtD
Etoricoxib—Pancreatitis—Doxorubicin—kidney cancer	3.82e-05	0.000281	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.82e-05	0.000281	CcSEcCtD
Etoricoxib—Angina pectoris—Doxorubicin—kidney cancer	3.8e-05	0.000279	CcSEcCtD
Etoricoxib—Insomnia—Paclitaxel—kidney cancer	3.79e-05	0.000279	CcSEcCtD
Etoricoxib—Asthenia—Vincristine—kidney cancer	3.79e-05	0.000278	CcSEcCtD
Etoricoxib—Vomiting—Dactinomycin—kidney cancer	3.76e-05	0.000276	CcSEcCtD
Etoricoxib—Bronchitis—Doxorubicin—kidney cancer	3.75e-05	0.000276	CcSEcCtD
Etoricoxib—Dyspnoea—Paclitaxel—kidney cancer	3.74e-05	0.000275	CcSEcCtD
Etoricoxib—Somnolence—Paclitaxel—kidney cancer	3.73e-05	0.000274	CcSEcCtD
Etoricoxib—Palpitations—Capecitabine—kidney cancer	3.72e-05	0.000274	CcSEcCtD
Etoricoxib—Rash—Dactinomycin—kidney cancer	3.72e-05	0.000274	CcSEcCtD
Etoricoxib—Nausea—Sunitinib—kidney cancer	3.71e-05	0.000272	CcSEcCtD
Etoricoxib—Dyspepsia—Paclitaxel—kidney cancer	3.69e-05	0.000271	CcSEcCtD
Etoricoxib—Cough—Capecitabine—kidney cancer	3.68e-05	0.00027	CcSEcCtD
Etoricoxib—Decreased appetite—Paclitaxel—kidney cancer	3.64e-05	0.000268	CcSEcCtD
Etoricoxib—Hypertension—Capecitabine—kidney cancer	3.64e-05	0.000267	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Doxorubicin—kidney cancer	3.62e-05	0.000266	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.62e-05	0.000266	CcSEcCtD
Etoricoxib—Fatigue—Paclitaxel—kidney cancer	3.61e-05	0.000266	CcSEcCtD
Etoricoxib—Diarrhoea—Vincristine—kidney cancer	3.61e-05	0.000265	CcSEcCtD
Etoricoxib—Asthenia—Gemcitabine—kidney cancer	3.59e-05	0.000264	CcSEcCtD
Etoricoxib—Arthralgia—Capecitabine—kidney cancer	3.59e-05	0.000264	CcSEcCtD
Etoricoxib—Chest pain—Capecitabine—kidney cancer	3.59e-05	0.000264	CcSEcCtD
Etoricoxib—Pain—Paclitaxel—kidney cancer	3.58e-05	0.000263	CcSEcCtD
Etoricoxib—Constipation—Paclitaxel—kidney cancer	3.58e-05	0.000263	CcSEcCtD
Etoricoxib—Anxiety—Capecitabine—kidney cancer	3.58e-05	0.000263	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	3.56e-05	0.000262	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Doxorubicin—kidney cancer	3.56e-05	0.000261	CcSEcCtD
Etoricoxib—Weight increased—Doxorubicin—kidney cancer	3.55e-05	0.000261	CcSEcCtD
Etoricoxib—Pruritus—Gemcitabine—kidney cancer	3.54e-05	0.00026	CcSEcCtD
Etoricoxib—Hyperglycaemia—Doxorubicin—kidney cancer	3.52e-05	0.000258	CcSEcCtD
Etoricoxib—Dry mouth—Capecitabine—kidney cancer	3.51e-05	0.000258	CcSEcCtD
Etoricoxib—Nausea—Dactinomycin—kidney cancer	3.51e-05	0.000258	CcSEcCtD
Etoricoxib—Pneumonia—Doxorubicin—kidney cancer	3.5e-05	0.000257	CcSEcCtD
Etoricoxib—Dizziness—Vincristine—kidney cancer	3.49e-05	0.000256	CcSEcCtD
Etoricoxib—Infestation NOS—Doxorubicin—kidney cancer	3.48e-05	0.000255	CcSEcCtD
Etoricoxib—Infestation—Doxorubicin—kidney cancer	3.48e-05	0.000255	CcSEcCtD
Etoricoxib—Confusional state—Capecitabine—kidney cancer	3.47e-05	0.000255	CcSEcCtD
Etoricoxib—Feeling abnormal—Paclitaxel—kidney cancer	3.45e-05	0.000254	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	3.45e-05	0.000253	CcSEcCtD
Etoricoxib—Oedema—Capecitabine—kidney cancer	3.44e-05	0.000253	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Paclitaxel—kidney cancer	3.43e-05	0.000252	CcSEcCtD
Etoricoxib—Diarrhoea—Gemcitabine—kidney cancer	3.42e-05	0.000252	CcSEcCtD
Etoricoxib—Renal failure—Doxorubicin—kidney cancer	3.42e-05	0.000251	CcSEcCtD
Etoricoxib—Infection—Capecitabine—kidney cancer	3.42e-05	0.000251	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Doxorubicin—kidney cancer	3.41e-05	0.00025	CcSEcCtD
Etoricoxib—Jaundice—Doxorubicin—kidney cancer	3.39e-05	0.000249	CcSEcCtD
Etoricoxib—Stomatitis—Doxorubicin—kidney cancer	3.39e-05	0.000249	CcSEcCtD
Etoricoxib—Shock—Capecitabine—kidney cancer	3.38e-05	0.000249	CcSEcCtD
Etoricoxib—Conjunctivitis—Doxorubicin—kidney cancer	3.38e-05	0.000248	CcSEcCtD
Etoricoxib—Urinary tract infection—Doxorubicin—kidney cancer	3.38e-05	0.000248	CcSEcCtD
Etoricoxib—Nervous system disorder—Capecitabine—kidney cancer	3.37e-05	0.000248	CcSEcCtD
Etoricoxib—Thrombocytopenia—Capecitabine—kidney cancer	3.37e-05	0.000247	CcSEcCtD
Etoricoxib—Vomiting—Vincristine—kidney cancer	3.36e-05	0.000247	CcSEcCtD
Etoricoxib—Skin disorder—Capecitabine—kidney cancer	3.34e-05	0.000245	CcSEcCtD
Etoricoxib—Urticaria—Paclitaxel—kidney cancer	3.33e-05	0.000245	CcSEcCtD
Etoricoxib—Rash—Vincristine—kidney cancer	3.33e-05	0.000244	CcSEcCtD
Etoricoxib—Dermatitis—Vincristine—kidney cancer	3.32e-05	0.000244	CcSEcCtD
Etoricoxib—Haematuria—Doxorubicin—kidney cancer	3.31e-05	0.000244	CcSEcCtD
Etoricoxib—Abdominal pain—Paclitaxel—kidney cancer	3.31e-05	0.000243	CcSEcCtD
Etoricoxib—Headache—Vincristine—kidney cancer	3.31e-05	0.000243	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Doxorubicin—kidney cancer	3.29e-05	0.000242	CcSEcCtD
Etoricoxib—Epistaxis—Doxorubicin—kidney cancer	3.28e-05	0.000241	CcSEcCtD
Etoricoxib—Anorexia—Capecitabine—kidney cancer	3.28e-05	0.000241	CcSEcCtD
Etoricoxib—Sinusitis—Doxorubicin—kidney cancer	3.26e-05	0.00024	CcSEcCtD
Etoricoxib—Vomiting—Gemcitabine—kidney cancer	3.18e-05	0.000234	CcSEcCtD
Etoricoxib—Rash—Gemcitabine—kidney cancer	3.16e-05	0.000232	CcSEcCtD
Etoricoxib—Dermatitis—Gemcitabine—kidney cancer	3.15e-05	0.000232	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—kidney cancer	3.14e-05	0.00023	CcSEcCtD
Etoricoxib—Headache—Gemcitabine—kidney cancer	3.14e-05	0.00023	CcSEcCtD
Etoricoxib—Nausea—Vincristine—kidney cancer	3.13e-05	0.00023	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.13e-05	0.00023	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—kidney cancer	3.12e-05	0.000229	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—kidney cancer	3.12e-05	0.000229	CcSEcCtD
Etoricoxib—Insomnia—Capecitabine—kidney cancer	3.11e-05	0.000229	CcSEcCtD
Etoricoxib—Hypoaesthesia—Doxorubicin—kidney cancer	3.1e-05	0.000228	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—kidney cancer	3.1e-05	0.000228	CcSEcCtD
Etoricoxib—Hypersensitivity—Paclitaxel—kidney cancer	3.09e-05	0.000227	CcSEcCtD
Etoricoxib—Urinary tract disorder—Doxorubicin—kidney cancer	3.08e-05	0.000226	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—kidney cancer	3.07e-05	0.000226	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—kidney cancer	3.07e-05	0.000225	CcSEcCtD
Etoricoxib—Dyspnoea—Capecitabine—kidney cancer	3.07e-05	0.000225	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—kidney cancer	3.06e-05	0.000225	CcSEcCtD
Etoricoxib—Dyspepsia—Capecitabine—kidney cancer	3.03e-05	0.000222	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—kidney cancer	3.01e-05	0.000221	CcSEcCtD
Etoricoxib—Asthenia—Paclitaxel—kidney cancer	3.01e-05	0.000221	CcSEcCtD
Etoricoxib—Decreased appetite—Capecitabine—kidney cancer	2.99e-05	0.00022	CcSEcCtD
Etoricoxib—Nausea—Gemcitabine—kidney cancer	2.97e-05	0.000218	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Capecitabine—kidney cancer	2.97e-05	0.000218	CcSEcCtD
Etoricoxib—Fatigue—Capecitabine—kidney cancer	2.97e-05	0.000218	CcSEcCtD
Etoricoxib—Pruritus—Paclitaxel—kidney cancer	2.97e-05	0.000218	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—kidney cancer	2.95e-05	0.000217	CcSEcCtD
Etoricoxib—Constipation—Capecitabine—kidney cancer	2.94e-05	0.000216	CcSEcCtD
Etoricoxib—Pain—Capecitabine—kidney cancer	2.94e-05	0.000216	CcSEcCtD
Etoricoxib—Eye disorder—Doxorubicin—kidney cancer	2.92e-05	0.000214	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—kidney cancer	2.91e-05	0.000214	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—kidney cancer	2.9e-05	0.000213	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—kidney cancer	2.9e-05	0.000213	CcSEcCtD
Etoricoxib—Diarrhoea—Paclitaxel—kidney cancer	2.87e-05	0.000211	CcSEcCtD
Etoricoxib—Feeling abnormal—Capecitabine—kidney cancer	2.83e-05	0.000208	CcSEcCtD
Etoricoxib—Angiopathy—Doxorubicin—kidney cancer	2.83e-05	0.000208	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—kidney cancer	2.82e-05	0.000207	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Capecitabine—kidney cancer	2.81e-05	0.000207	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—kidney cancer	2.81e-05	0.000207	CcSEcCtD
Etoricoxib—Arrhythmia—Doxorubicin—kidney cancer	2.79e-05	0.000205	CcSEcCtD
Etoricoxib—Dizziness—Paclitaxel—kidney cancer	2.77e-05	0.000204	CcSEcCtD
Etoricoxib—Alopecia—Doxorubicin—kidney cancer	2.76e-05	0.000203	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—kidney cancer	2.73e-05	0.000201	CcSEcCtD
Etoricoxib—Urticaria—Capecitabine—kidney cancer	2.73e-05	0.000201	CcSEcCtD
Etoricoxib—Abdominal pain—Capecitabine—kidney cancer	2.72e-05	0.0002	CcSEcCtD
Etoricoxib—Erythema—Doxorubicin—kidney cancer	2.72e-05	0.0002	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—kidney cancer	2.72e-05	0.0002	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—kidney cancer	2.68e-05	0.000197	CcSEcCtD
Etoricoxib—Vomiting—Paclitaxel—kidney cancer	2.66e-05	0.000196	CcSEcCtD
Etoricoxib—Dysgeusia—Doxorubicin—kidney cancer	2.66e-05	0.000195	CcSEcCtD
Etoricoxib—Rash—Paclitaxel—kidney cancer	2.64e-05	0.000194	CcSEcCtD
Etoricoxib—Dermatitis—Paclitaxel—kidney cancer	2.64e-05	0.000194	CcSEcCtD
Etoricoxib—Headache—Paclitaxel—kidney cancer	2.63e-05	0.000193	CcSEcCtD
Etoricoxib—Muscle spasms—Doxorubicin—kidney cancer	2.61e-05	0.000192	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—kidney cancer	2.56e-05	0.000188	CcSEcCtD
Etoricoxib—Hypersensitivity—Capecitabine—kidney cancer	2.53e-05	0.000186	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—kidney cancer	2.51e-05	0.000184	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—kidney cancer	2.5e-05	0.000183	CcSEcCtD
Etoricoxib—Nausea—Paclitaxel—kidney cancer	2.49e-05	0.000183	CcSEcCtD
Etoricoxib—Asthenia—Capecitabine—kidney cancer	2.47e-05	0.000181	CcSEcCtD
Etoricoxib—Pruritus—Capecitabine—kidney cancer	2.43e-05	0.000179	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—kidney cancer	2.4e-05	0.000176	CcSEcCtD
Etoricoxib—Cough—Doxorubicin—kidney cancer	2.37e-05	0.000174	CcSEcCtD
Etoricoxib—Diarrhoea—Capecitabine—kidney cancer	2.35e-05	0.000173	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—kidney cancer	2.35e-05	0.000172	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—kidney cancer	2.31e-05	0.00017	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—kidney cancer	2.31e-05	0.00017	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—kidney cancer	2.3e-05	0.000169	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.3e-05	0.000169	CcSEcCtD
Etoricoxib—Dizziness—Capecitabine—kidney cancer	2.27e-05	0.000167	CcSEcCtD
Etoricoxib—Dry mouth—Doxorubicin—kidney cancer	2.26e-05	0.000166	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—kidney cancer	2.24e-05	0.000164	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—kidney cancer	2.22e-05	0.000163	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—kidney cancer	2.22e-05	0.000163	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—kidney cancer	2.2e-05	0.000162	CcSEcCtD
Etoricoxib—Vomiting—Capecitabine—kidney cancer	2.19e-05	0.000161	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—kidney cancer	2.18e-05	0.00016	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—kidney cancer	2.17e-05	0.00016	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—kidney cancer	2.17e-05	0.00016	CcSEcCtD
Etoricoxib—Rash—Capecitabine—kidney cancer	2.17e-05	0.000159	CcSEcCtD
Etoricoxib—Dermatitis—Capecitabine—kidney cancer	2.17e-05	0.000159	CcSEcCtD
Etoricoxib—Headache—Capecitabine—kidney cancer	2.15e-05	0.000158	CcSEcCtD
Etoricoxib—Skin disorder—Doxorubicin—kidney cancer	2.15e-05	0.000158	CcSEcCtD
Etoricoxib—Anorexia—Doxorubicin—kidney cancer	2.11e-05	0.000155	CcSEcCtD
Etoricoxib—Nausea—Capecitabine—kidney cancer	2.04e-05	0.00015	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.02e-05	0.000148	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—kidney cancer	2.01e-05	0.000147	CcSEcCtD
Etoricoxib—Dyspnoea—Doxorubicin—kidney cancer	1.98e-05	0.000145	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—kidney cancer	1.97e-05	0.000145	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—kidney cancer	1.95e-05	0.000143	CcSEcCtD
Etoricoxib—Decreased appetite—Doxorubicin—kidney cancer	1.93e-05	0.000142	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.91e-05	0.000141	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—kidney cancer	1.91e-05	0.00014	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—kidney cancer	1.9e-05	0.000139	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—kidney cancer	1.9e-05	0.000139	CcSEcCtD
Etoricoxib—Feeling abnormal—Doxorubicin—kidney cancer	1.83e-05	0.000134	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Doxorubicin—kidney cancer	1.81e-05	0.000133	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—kidney cancer	1.76e-05	0.000129	CcSEcCtD
Etoricoxib—Abdominal pain—Doxorubicin—kidney cancer	1.75e-05	0.000129	CcSEcCtD
Etoricoxib—Hypersensitivity—Doxorubicin—kidney cancer	1.63e-05	0.00012	CcSEcCtD
Etoricoxib—Asthenia—Doxorubicin—kidney cancer	1.59e-05	0.000117	CcSEcCtD
Etoricoxib—Pruritus—Doxorubicin—kidney cancer	1.57e-05	0.000115	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—kidney cancer	1.52e-05	0.000111	CcSEcCtD
Etoricoxib—Dizziness—Doxorubicin—kidney cancer	1.47e-05	0.000108	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—kidney cancer	1.41e-05	0.000104	CcSEcCtD
Etoricoxib—Rash—Doxorubicin—kidney cancer	1.4e-05	0.000103	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—kidney cancer	1.4e-05	0.000103	CcSEcCtD
Etoricoxib—Headache—Doxorubicin—kidney cancer	1.39e-05	0.000102	CcSEcCtD
Etoricoxib—Nausea—Doxorubicin—kidney cancer	1.32e-05	9.68e-05	CcSEcCtD
Etoricoxib—CYP3A4—Metabolism—CCBL1—kidney cancer	7.88e-06	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—TSC2—kidney cancer	7.88e-06	0.000113	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PGK1—kidney cancer	7.86e-06	0.000113	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC5A3—kidney cancer	7.86e-06	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PAK1—kidney cancer	7.85e-06	0.000113	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JUNB—kidney cancer	7.85e-06	0.000113	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—LDHB—kidney cancer	7.77e-06	0.000112	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPC3—kidney cancer	7.74e-06	0.000111	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—LDHB—kidney cancer	7.7e-06	0.000111	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MAPK3—kidney cancer	7.66e-06	0.00011	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CA2—kidney cancer	7.53e-06	0.000108	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MAPK3—kidney cancer	7.51e-06	0.000108	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ITPR2—kidney cancer	7.51e-06	0.000108	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.35e-06	0.000106	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALAD—kidney cancer	7.34e-06	0.000106	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CA9—kidney cancer	7.33e-06	0.000105	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MAPK1—kidney cancer	7.29e-06	0.000105	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ACHE—kidney cancer	7.27e-06	0.000105	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTT1—kidney cancer	7.27e-06	0.000105	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SLC2A1—kidney cancer	7.21e-06	0.000104	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ST3GAL2—kidney cancer	7.16e-06	0.000103	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—JUNB—kidney cancer	7.16e-06	0.000103	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.16e-06	0.000103	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MAPK1—kidney cancer	7.15e-06	0.000103	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALDH1A1—kidney cancer	7e-06	0.000101	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KIT—kidney cancer	6.96e-06	0.0001	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SCARB1—kidney cancer	6.88e-06	9.9e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—KRAS—kidney cancer	6.88e-06	9.9e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ACHE—kidney cancer	6.84e-06	9.84e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTT1—kidney cancer	6.84e-06	9.84e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPAT—kidney cancer	6.84e-06	9.83e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GLIPR1—kidney cancer	6.84e-06	9.83e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTGS1—kidney cancer	6.81e-06	9.8e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK3—kidney cancer	6.76e-06	9.72e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—KRAS—kidney cancer	6.75e-06	9.71e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CA9—kidney cancer	6.74e-06	9.69e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC5A3—kidney cancer	6.71e-06	9.65e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PGK1—kidney cancer	6.71e-06	9.65e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PSMD7—kidney cancer	6.68e-06	9.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CA9—kidney cancer	6.68e-06	9.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—LDHB—kidney cancer	6.58e-06	9.47e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.53e-06	9.39e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SCARB1—kidney cancer	6.48e-06	9.32e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—MAPK1—kidney cancer	6.43e-06	9.25e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF2—kidney cancer	6.42e-06	9.23e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS1—kidney cancer	6.41e-06	9.22e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDH1—kidney cancer	6.41e-06	9.21e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN2B—kidney cancer	6.39e-06	9.19e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FH—kidney cancer	6.35e-06	9.14e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—APRT—kidney cancer	6.35e-06	9.14e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—BCHE—kidney cancer	6.33e-06	9.11e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PSMD7—kidney cancer	6.29e-06	9.04e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC5A5—kidney cancer	6.26e-06	9e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CRABP1—kidney cancer	6.23e-06	8.96e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1R—kidney cancer	6.21e-06	8.92e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—PIK3CA—kidney cancer	6.2e-06	8.92e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—KRAS—kidney cancer	6.08e-06	8.74e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC2A1—kidney cancer	6.04e-06	8.69e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—kidney cancer	6e-06	8.63e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPC3—kidney cancer	5.97e-06	8.59e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—BCHE—kidney cancer	5.96e-06	8.57e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC5A5—kidney cancer	5.89e-06	8.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN2B—kidney cancer	5.83e-06	8.38e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CA2—kidney cancer	5.81e-06	8.36e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ITPR2—kidney cancer	5.79e-06	8.33e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CRABP1—kidney cancer	5.73e-06	8.24e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CA9—kidney cancer	5.71e-06	8.21e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC2A1—kidney cancer	5.69e-06	8.18e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CRABP1—kidney cancer	5.68e-06	8.17e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALAD—kidney cancer	5.66e-06	8.15e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PIK3CA—kidney cancer	5.58e-06	8.03e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.58e-06	8.02e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.53e-06	7.95e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RAF1—kidney cancer	5.46e-06	7.86e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—RELA—kidney cancer	5.44e-06	7.82e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—ERBB2—kidney cancer	5.41e-06	7.77e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.4e-06	7.77e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.34e-06	7.68e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MTOR—kidney cancer	5.33e-06	7.67e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ITPR2—kidney cancer	5.33e-06	7.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CD4—kidney cancer	5.32e-06	7.66e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ACHE—kidney cancer	5.28e-06	7.59e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTT1—kidney cancer	5.28e-06	7.59e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ITPR2—kidney cancer	5.28e-06	7.59e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PGK1—kidney cancer	5.18e-06	7.45e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.18e-06	7.45e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.11e-06	7.35e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HIF1A—kidney cancer	5.11e-06	7.35e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TSC2—kidney cancer	5.1e-06	7.33e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—LDHB—kidney cancer	5.08e-06	7.31e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTP1—kidney cancer	5.04e-06	7.25e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDKN1B—kidney cancer	5.01e-06	7.2e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SCARB1—kidney cancer	5e-06	7.19e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS1—kidney cancer	4.95e-06	7.12e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL2—kidney cancer	4.9e-06	7.05e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KDR—kidney cancer	4.89e-06	7.03e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.87e-06	7e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTT1—kidney cancer	4.86e-06	6.98e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ACHE—kidney cancer	4.86e-06	6.98e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CRABP1—kidney cancer	4.85e-06	6.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PSMD7—kidney cancer	4.85e-06	6.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ACHE—kidney cancer	4.81e-06	6.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTT1—kidney cancer	4.81e-06	6.92e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ABCB1—kidney cancer	4.77e-06	6.86e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—JUN—kidney cancer	4.77e-06	6.85e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTP1—kidney cancer	4.74e-06	6.82e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTNNB1—kidney cancer	4.73e-06	6.8e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HIF1A—kidney cancer	4.66e-06	6.7e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TSC2—kidney cancer	4.65e-06	6.69e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTM1—kidney cancer	4.63e-06	6.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTEN—kidney cancer	4.61e-06	6.63e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—BCHE—kidney cancer	4.6e-06	6.62e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SCARB1—kidney cancer	4.6e-06	6.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SCARB1—kidney cancer	4.56e-06	6.55e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS1—kidney cancer	4.55e-06	6.54e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.54e-06	6.53e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ITPR2—kidney cancer	4.51e-06	6.49e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS1—kidney cancer	4.51e-06	6.49e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KIT—kidney cancer	4.5e-06	6.47e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—APC—kidney cancer	4.5e-06	6.47e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ABCB1—kidney cancer	4.49e-06	6.46e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PSMD7—kidney cancer	4.46e-06	6.42e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PSMD7—kidney cancer	4.42e-06	6.36e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CA9—kidney cancer	4.4e-06	6.33e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CYP1A1—kidney cancer	4.39e-06	6.31e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.39e-06	6.31e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTM1—kidney cancer	4.36e-06	6.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—POMC—kidney cancer	4.28e-06	6.16e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.26e-06	6.12e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—BCHE—kidney cancer	4.23e-06	6.08e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BRAF—kidney cancer	4.23e-06	6.08e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—BCHE—kidney cancer	4.19e-06	6.03e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.18e-06	6.01e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.16e-06	5.98e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.14e-06	5.96e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CYP1A1—kidney cancer	4.13e-06	5.94e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ACHE—kidney cancer	4.11e-06	5.92e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTT1—kidney cancer	4.11e-06	5.92e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—APC—kidney cancer	4.11e-06	5.9e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KIT—kidney cancer	4.11e-06	5.9e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.04e-06	5.8e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC2A1—kidney cancer	4e-06	5.75e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK3—kidney cancer	3.94e-06	5.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MAPK3—kidney cancer	3.92e-06	5.63e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SCARB1—kidney cancer	3.89e-06	5.6e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.88e-06	5.58e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—BRAF—kidney cancer	3.86e-06	5.55e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS1—kidney cancer	3.86e-06	5.54e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—MYC—kidney cancer	3.81e-06	5.48e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PSMD7—kidney cancer	3.78e-06	5.44e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—MAPK1—kidney cancer	3.75e-06	5.39e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CRABP1—kidney cancer	3.75e-06	5.39e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.71e-06	5.34e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTP1—kidney cancer	3.66e-06	5.26e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.61e-06	5.19e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BCHE—kidney cancer	3.58e-06	5.15e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.54e-06	5.09e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KRAS—kidney cancer	3.54e-06	5.09e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RAF1—kidney cancer	3.53e-06	5.08e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RELA—kidney cancer	3.52e-06	5.06e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ERBB2—kidney cancer	3.49e-06	5.03e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ITPR2—kidney cancer	3.48e-06	5.01e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCB1—kidney cancer	3.46e-06	4.98e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MTOR—kidney cancer	3.45e-06	4.96e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.42e-06	4.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.39e-06	4.87e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTP1—kidney cancer	3.37e-06	4.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTM1—kidney cancer	3.36e-06	4.84e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTP1—kidney cancer	3.34e-06	4.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.32e-06	4.77e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—POMC—kidney cancer	3.27e-06	4.71e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CA—kidney cancer	3.25e-06	4.68e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1B—kidney cancer	3.24e-06	4.65e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RAF1—kidney cancer	3.22e-06	4.63e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.19e-06	4.59e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERBB2—kidney cancer	3.19e-06	4.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCB1—kidney cancer	3.19e-06	4.58e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTT1—kidney cancer	3.18e-06	4.57e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ACHE—kidney cancer	3.18e-06	4.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—kidney cancer	3.17e-06	4.55e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCB1—kidney cancer	3.16e-06	4.54e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTOR—kidney cancer	3.15e-06	4.52e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—kidney cancer	3.14e-06	4.52e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTM1—kidney cancer	3.09e-06	4.45e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCND1—kidney cancer	3.09e-06	4.44e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—POMC—kidney cancer	3.08e-06	4.43e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JUN—kidney cancer	3.08e-06	4.43e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTM1—kidney cancer	3.07e-06	4.41e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—kidney cancer	3.06e-06	4.4e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SCARB1—kidney cancer	3.01e-06	4.32e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTEN—kidney cancer	2.98e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS1—kidney cancer	2.98e-06	4.28e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1B—kidney cancer	2.95e-06	4.25e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.93e-06	4.22e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PSMD7—kidney cancer	2.92e-06	4.2e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.91e-06	4.18e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.89e-06	4.16e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTP1—kidney cancer	2.85e-06	4.1e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—kidney cancer	2.79e-06	4.01e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BCHE—kidney cancer	2.77e-06	3.98e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.73e-06	3.93e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PTEN—kidney cancer	2.72e-06	3.91e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCB1—kidney cancer	2.7e-06	3.88e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—kidney cancer	2.69e-06	3.87e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.64e-06	3.8e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTM1—kidney cancer	2.62e-06	3.77e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.62e-06	3.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK3—kidney cancer	2.55e-06	3.66e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.48e-06	3.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—kidney cancer	2.48e-06	3.56e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—kidney cancer	2.46e-06	3.53e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK1—kidney cancer	2.42e-06	3.48e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.39e-06	3.43e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—POMC—kidney cancer	2.38e-06	3.42e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAPK3—kidney cancer	2.32e-06	3.34e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KRAS—kidney cancer	2.29e-06	3.29e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTEN—kidney cancer	2.28e-06	3.27e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—kidney cancer	2.26e-06	3.25e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAPK1—kidney cancer	2.21e-06	3.18e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTP1—kidney cancer	2.2e-06	3.17e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—POMC—kidney cancer	2.19e-06	3.14e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—POMC—kidney cancer	2.17e-06	3.12e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTEN—kidney cancer	2.14e-06	3.08e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CA—kidney cancer	2.1e-06	3.02e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KRAS—kidney cancer	2.09e-06	3e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCB1—kidney cancer	2.08e-06	3e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.04e-06	2.94e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—kidney cancer	2.03e-06	2.92e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTM1—kidney cancer	2.02e-06	2.91e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CA—kidney cancer	1.92e-06	2.76e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.92e-06	2.76e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—kidney cancer	1.9e-06	2.73e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—POMC—kidney cancer	1.85e-06	2.66e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—kidney cancer	1.74e-06	2.51e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—kidney cancer	1.73e-06	2.49e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTEN—kidney cancer	1.65e-06	2.38e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CA—kidney cancer	1.61e-06	2.31e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTEN—kidney cancer	1.52e-06	2.19e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.51e-06	2.17e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTEN—kidney cancer	1.51e-06	2.17e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—kidney cancer	1.48e-06	2.12e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—POMC—kidney cancer	1.43e-06	2.06e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTEN—kidney cancer	1.29e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.17e-06	1.68e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—kidney cancer	1.14e-06	1.64e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.07e-06	1.54e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.06e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTEN—kidney cancer	9.94e-07	1.43e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.09e-07	1.31e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.02e-07	1.01e-05	CbGpPWpGaD
